Datasheet | October 15, 2014

Trimentum™ Sequential Parallel Comparison Design Datasheet

Source: PPD

With experience conducting studies covering a broad range of neurological, psychiatric and pain disorders, PPD’s team of experienced drug development professionals can expertly manage the complexities of your neuroscience trials. As part of our continuous effort to provide industry-leading neuroscience capabilities, PPD offers biopharmaceutical companies an innovative methodology for conducting clinical trials known as sequential parallel comparison design (SPCD), which PPD brands as Trimentum™. This design was initially developed by researchers at Massachusetts General Hospital; assessments of this design have been published by statisticians at the U.S. Food and Drug Administration (FDA). Applicability for use in registration clinical trials in depression has been successfully considered by regulator stakeholders.